Literature DB >> 17174975

eNOS phosphorylation: a pivotal molecular switch in vasodilation and cardioprotection?

Rakesh C Kukreja, Lei Xi.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 17174975      PMCID： PMC3031790          DOI： 10.1016/j.yjmcc.2006.10.011

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN： 0022-2828            Impact factor:   5.000


× No keyword cloud information.
  35 in total

1.  Aging enhances the sensitivity of endothelial cells toward apoptotic stimuli: important role of nitric oxide.

Authors:  J Hoffmann; J Haendeler; A Aicher; L Rössig; M Vasa; A M Zeiher; S Dimmeler
Journal:  Circ Res       Date:  2001-10-12       Impact factor: 17.367

Review 2.  Pivotal role of nitric oxide in delayed pharmacological preconditioning against myocardial infarction.

Authors:  L Xi; R C Kukreja
Journal:  Toxicology       Date:  2000-11-30       Impact factor: 4.221

Review 3.  Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough?

Authors:  D Fulton; J P Gratton; W C Sessa
Journal:  J Pharmacol Exp Ther       Date:  2001-12       Impact factor: 4.030

4.  Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation.

Authors:  Feng Gao; Erhe Gao; Tian-Li Yue; Eliot H Ohlstein; Bernard L Lopez; Theodore A Christopher; Xin-Liang Ma
Journal:  Circulation       Date:  2002-03-26       Impact factor: 29.690

5.  The contribution of endothelial nitric oxide synthase to early ischaemic preconditioning: the lowering of the preconditioning threshold. An investigation in eNOS knockout mice.

Authors:  R M Bell; D M Yellon
Journal:  Cardiovasc Res       Date:  2001-11       Impact factor: 10.787

Review 6.  Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation.

Authors:  Peter F Mount; Bruce E Kemp; David A Power
Journal:  J Mol Cell Cardiol       Date:  2006-07-12       Impact factor: 5.000

7.  Cardioprotection mediated by rosiglitazone, a peroxisome proliferator-activated receptor gamma ligand, in relation to nitric oxide.

Authors:  Adrian T Gonon; Aliaksandr Bulhak; Fausto Labruto; Per-Ove Sjöquist; John Pernow
Journal:  Basic Res Cardiol       Date:  2006-08-14       Impact factor: 17.165

8.  Bradykinin limits infarction when administered as an adjunct to reperfusion in mouse heart: the role of PI3K, Akt and eNOS.

Authors:  Robert M Bell; Derek M Yellon
Journal:  J Mol Cell Cardiol       Date:  2003-02       Impact factor: 5.000

Review 9.  Protein interactions with nitric oxide synthases: controlling the right time, the right place, and the right amount of nitric oxide.

Authors:  Bruce C Kone; Teresa Kuncewicz; Wenzheng Zhang; Zhi-Yuan Yu
Journal:  Am J Physiol Renal Physiol       Date:  2003-08

10.  Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway.

Authors:  Robert M Bell; Derek M Yellon
Journal:  J Am Coll Cardiol       Date:  2003-02-05       Impact factor: 24.094
View more
  24 in total

1.  Apolipoprotein E favours the blunting by high-fat diet of prostacyclin receptor activation in the mouse aorta.

Authors:  Yanhua Cheng; Paul M Vanhoutte; Susan W S Leung
Journal:  Br J Pharmacol       Date:  2018-07-22       Impact factor: 8.739

2.  Early ischaemic preconditioning requires Akt- and PKA-mediated activation of eNOS via serine1176 phosphorylation.

Authors:  Changjun Yang; M A Hassan Talukder; Saradhadevi Varadharaj; Murugesan Velayutham; Jay L Zweier
Journal:  Cardiovasc Res       Date:  2012-09-12       Impact factor: 10.787

3.  Liposomal tetrahydrobiopterin preserves eNOS coupling in the post-ischemic heart conferring in vivo cardioprotection.

Authors:  Lin Xie; M A Hassan Talukder; Jian Sun; Saradhadevi Varadharaj; Jay L Zweier
Journal:  J Mol Cell Cardiol       Date:  2015-06-25       Impact factor: 5.000

4.  Alcohol and maternal uterine vascular adaptations during pregnancy-part I: effects of chronic in vitro binge-like alcohol on uterine endothelial nitric oxide system and function.

Authors:  Jayanth Ramadoss; Sheikh O Jobe; Ronald R Magness
Journal:  Alcohol Clin Exp Res       Date:  2011-05-20       Impact factor: 3.455

5.  TM-1-1DP exerts protective effect against myocardial ischemia reperfusion injury via AKT-eNOS pathway.

Authors:  Hui-Chun Ku; Shih-Yi Lee; Chi-Hsuan Chen; Yao-Hsing Wang; Chin-Ting Lin; Shoei-Sheng Lee; Ting-Hsuan Li; Ming-Jai Su
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-02-13       Impact factor: 3.000

6.  Dietary phosphorus acutely impairs endothelial function.

Authors:  Emi Shuto; Yutaka Taketani; Rieko Tanaka; Nagakatsu Harada; Masashi Isshiki; Minako Sato; Kunitaka Nashiki; Kikuko Amo; Hironori Yamamoto; Yukihito Higashi; Yutaka Nakaya; Eiji Takeda
Journal:  J Am Soc Nephrol       Date:  2009-04-30       Impact factor: 10.121

7.  Chronic inhibition of phosphodiesterase 5 with tadalafil attenuates mitochondrial dysfunction in type 2 diabetic hearts: potential role of NO/SIRT1/PGC-1α signaling.

Authors:  Saisudha Koka; Hema S Aluri; Lei Xi; Edward J Lesnefsky; Rakesh C Kukreja
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-04-11       Impact factor: 4.733

8.  Influence of progesterone on endometrial nitric oxide synthase expression.

Authors:  Omid Khorram; Guang Han
Journal:  Fertil Steril       Date:  2008-08-16       Impact factor: 7.329

9.  Vascular endothelial growth factor regulation of endothelial nitric oxide synthase phosphorylation is involved in isoflurane cardiac preconditioning.

Authors:  Yanan Liu; Mark Paterson; Shelley L Baumgardt; Michael G Irwin; Zhengyuan Xia; Zeljko J Bosnjak; Zhi-Dong Ge
Journal:  Cardiovasc Res       Date:  2019-01-01       Impact factor: 10.787

10.  Protective effects of PARP-1 knockout on dyslipidemia-induced autonomic and vascular dysfunction in ApoE mice: effects on eNOS and oxidative stress.

Authors:  Chetan P Hans; Yumei Feng; Amarjit S Naura; Mourad Zerfaoui; Bashir M Rezk; Huijing Xia; Alan D Kaye; Khalid Matrougui; Eric Lazartigues; A Hamid Boulares
Journal:  PLoS One       Date:  2009-10-13       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.